品牌 |
貨號 |
產(chǎn)品名稱 |
規(guī)格 |
貨期 |
單價 |
操作 |
Molecular Innovations | UPA-LMW-FITC-1.0mg | Human LMW urokinase, fluorescein labeled | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | UPA-LMW-HRP-1.0mg | Human LMW urokinase, HRP conjugate | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HLRP-C2-FC-1.0mg | Human LRP1 Cluster II, chiMAX Fc Fusion Protein | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HLRP-C3-FC-1.0mg | Human LRP1 Cluster III, chiMAX Fc Fusion Protein | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HLRP-C4-FC-1.0mg | Human LRP1 Cluster IV, chiMAX Fc Fusion Protein | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HPLM-10mg | Human Lys plasmin | 10mg | | ¥0.00 | 詳情 |
Molecular Innovations | HVN-1.0mg | Human monomeric vitronectin | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HVN-U-1.0mg | Human multimeric vitronectin | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HNE-L-1.0mg | Human Neutrophil Elastase, Lyophilized | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | FPAI-1.0mg | Human PAI -1 Cathepsin G specific mutant | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | APAI-1.0mg | Human PAI -1 Elastase specific mutant | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | GLYCPAI-1.0mg | Human PAI-1 (Glycosylated - stable mutant) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | S119C-L-NBD-1.0mg | Human PAI-1 (NBD labeled vitronectin reporter mutant latent fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | S119C-NBD-1.0mg | Human PAI-1 (NBD labeled vitronectin reporter mutant) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | HPAI-AVI-1.0mg | Human PAI-1 (Neutrophil Elastase inhibitor) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTAF488CPAI-1.0mg | Human PAI-1 (N-terminal Alexa Fluor 488 labeled stable mutant) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTAF488PAI-A-1.0mg | Human PAI-1 (N-terminal Alexa Fluor 488 labeled, active fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTAF488PAI-L-1.0mg | Human PAI-1 (N-terminal Alexa Fluor 488 labeled, latent fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTAF594CPAI-1.0mg | Human PAI-1 (N-terminal Alexa Fluor 594 labeled stable mutant) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTAF594PAI-A-1.0mg | Human PAI-1 (N-terminal Alexa Fluor 594 labeled, active fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTAF594PAI-L-1.0mg | Human PAI-1 (N-terminal Alexa Fluor 594 labeled, latent fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTBIOCPAI-1.0mg | Human PAI-1 (N-terminal biotin labeled stable mutant) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTBIOPAI-A-1.0mg | Human PAI-1 (N-terminal biotin labeled, active fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTBIOPAI-L-1.0mg | Human PAI-1 (N-terminal biotin labeled, latent fraction) | 1.0mg | | ¥0.00 | 詳情 |
Molecular Innovations | NTCYSCPAI-R76E-1.0mg | Human PAI-1 (N-terminal cysteine LRP non-binding stable mutant) | 1.0mg | | ¥0.00 | 詳情 |